99% Purity Antidiabetic API Raw Material Linagliptin Powder CAS 668270-12-0

• CAS No.: 668270-12-0
• Formula: C25h28n8o2
• EINECS: 1308068-626-2
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Industrial
• Model NO.: FI-1739
• Colour: White
• Transport Package: Carton
• Specification: 25kg/carton
• Trademark: SCM Piopneering
• Origin: China
• HS Code: 29
• Production Capacity: 50000kg/Month

Product Description

 

API  Raw Material Linagliptin Powder CAS 668270-12-0 

Product Description

Linagliptin, a new generation of DPP-4 inhibitors (DPP) - 4 inhibitors), is a drug for diabetes. It is used to improve the control of blood sugar level in patients with type 2 diabetes by combining diet and exercise. "Lilalitine" is currently the only oral antidiabetic drug for DPP-4 inhibitor that is not mainly excreted through the kidney.

 

 

Application

Liggliptin was generated from the optimization of DPP-4 inhibitors based on xanthine, and the initial leader was determined from HTS activities. After optimizing the activity of initial micromolar lead, two problems need to be solved are the activity of hERG and muscarinic receptor M1.

Liggliptin is an oral and highly selective dipeptidyl peptidase-4 inhibitor, which is the first drug of this class to be eliminated mainly through non-aldehyde pathway. Liggliptin is suitable for the treatment of adult type 2 diabetes.

Free Samples

Free of charge.
We are ready to provide samples for you test, normally 20g/bag.

Packaging & Shipping

 

Standard export packing (25kg per bag).

As per customer's request

 

Company Profile

SCM Pioneering Co., Ltd is an emerging supplier of high quality ingredients which based in Shandong province, China.

SCM was established by group of experts who have more than ten years experiences in pharmaceutical and food ingredients industries. with our deep knowledge and diligence, together with our associated plants, we would like to provide one-stop sourcing solutions for customers, to save your time and secure your purchasing.
 

 

 

 

FAQ

1.What is Linagliptin ?
Linagliptin (trade names Tradjenta and Trajetna) is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that was approved by the U.S. FDA in May 2011 for the treatment of Type 2 diabetes along with diet and exercise. Linagliptin (BI-1356) has been described as a potent highly selective, slow-off rate and long acting inhibitor of DPP-4. 

2.Can I get some sample for test?

Sure, we can supply samples free for your test. 
 

3.Is Linagliptin suitable for long-distance ocean transport?
Yes. We understand your concern. The Linagliptin will be packed in 1kg Aluminum foil bag, and 25KG carton box,  then tray wrapped film, which is suitable for long-distance land and sea transportation. When shipping, we will apply for positions below the water level.

4.How can you guarantee the quality?
We have regular factory inspection to view the production status. And compare all qualified batches to select the best one for our customer before delivery.

5.When can you deliver goods if we confirm the order?
We will arrange the latest production batch for you, within seven days.

Dear friends, now contact us to get more benefit!